Sort
130,381 grants matching “hiv”
Clinical Trials Network Mid-Atlantic Collaborative Group
$1,134,513Maxine L Stitzer · Johns Hopkins University · U10 · FY2013 · DA
NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND
$1,134,396Harvard University (Sch Of Public Hlth) · R01 · FY2000 · HD
Making it last: A randomized, controlled trial of a home care system to promote persistence in PrEP care
$1,134,351Aaron Julius Siegler · Emory University · R01 · FY2019 · MH
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand
$1,134,326Gonzague Joseph Jourdain · Institute Of Research And Development · UM1 · FY2012 · AI
Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies
$1,134,239Raiees Ahmad Andrabi · Scripps Research Institute, The · R61 · FY2023 · AI
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$1,133,980Mark M Davis · Stanford University · U19 · FY2020 · AI
CENTER ON INTERSYSTEM REGULATION BY DRUGS OF ABUSE
$1,133,914Temple University · P30 · FY2003 · DA
Molecular and Cellular Biology of HIV Encephalopathy
$1,133,807Francisco A Gonzalez-Scarano · University Of Pennsylvania · P01 · FY2006 · NS
Miami Pediatric AIDS Clinical Trials Unit
$1,133,574University Of Miami School Of Medicine · U01 · FY2002 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$1,133,540Katharine June Bar · University Of Pennsylvania · R01 · FY2021 · MH
Development of an Ad5 [E1-, E2b-] HIV-1 vaccine for use in Ad5 Immunized Vaccinee
$1,133,414Frank R. Jones · Etubics Corporation · R44 · FY2011 · AI
A novel vaccine against multidrug-resistant gonorrhea
$1,133,414Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Papillomavirus Virion Proteins and Vaccines
$1,133,390Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Transmission Correlates
$1,133,353Douglas D Richman · University Of California, San Diego · P01 · FY2010 · AI
Randomized Control Trial of Positive Peers mHealth app as a clinic-based intervention to optimize HIV outcomes among young people with HIV
$1,133,269Ann K Avery · Case Western Reserve University · R01 · FY2025 · MD
Nmr Studies Of The Regulation Of Cell Signaling
$1,133,076Nico Tjandra · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance
$1,132,909Sarah Beth Joseph · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
A multi-level approach to improve HIV prevention and care for transgender women of color
$1,132,842Jae M. Sevelius · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2022 · MH
Developmental Core
$1,132,807Vinayaka R Prasad · Albert Einstein College Of Medicine · P30 · FY2019 · AI
Evaluation Of Treatments Of Opioid And Cocaine Dependence
$1,132,800Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2013 · DA
Alphavirus Replicon Vaccines against Marburg Virus
$1,132,626Alphavax Human Vaccines, Inc. · U01 · FY2002 · AI
Preclinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$1,132,507Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,132,476Johns Hopkins University · U01 · FY2005 · AI
Evaluation Of Treatments Of Opioid And Cocaine Dependence
$1,132,375Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2012 · DA
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$1,132,346Sung-Yun Pai · Boston Children'S Hospital · U01 · FY2016 · AI